A non-interventional, fully anonymized study for the comparative evaluation of a new direct detection methods for infection with SARS-CoV-2 (COVID-19) in clinical samples

A non-interventional, fully anonymized study for the comparative evaluation of a new direct detection methods for infection with SARS-CoV-2 (COVID-19) in clinical samples - LIF-nCov-2019

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023821

Enrollment

350

Registered

2020-12-11

Start date

2020-04-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 J12.8 J84.9

Interventions

Group 1: Evaluation of diagnostic method, comparison RT-PCR versus laser-induced fluorescence spectrospcopy for the diagnosis of SARS-CoV-2 infections Group 2: Evaluation of diagnostic method, compa

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Patients with respiratory symptoms

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Detection of SARS-CoV-2 genome by reverse transcriptase polymerase chain reaction (RT-PCR) (specific signal and ct value) versus LIF (laser-induced fluorescence spectroscopy, detection of a specific fluorescence emission spectrum) in respiratory specimen from patients with clinical symptoms of a respiratory infection.	—

Countries

Germany

Contacts

Public ContactMichael Kleines

Universitätsklinikum der RWTH Aachen

mkleines@ukaachen.de+49 241 80-88671

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026